Researchers at The University of Texas at El Paso (UTEP) have made significant strides in developing a novel therapeutic approach for treating skin and lung fibrosis. These conditions, characterised by the thickening and stiffening of tissues, can lead to severe damage in affected organs. Led by Dr. Md Nurunnabi, an associate professor in UTEP’s School of Pharmacy, the team’s findings offer hope for improved treatments that could enhance the quality of life for affected individuals.
Understanding Fibrosis